Efficacy and safety of treatment with Azilsartan in type 2 diabetes mellitus patients with hypertension who did not show target blood pressure by telmisartan.
Not Applicable
- Conditions
- Type 2 diabetes mellitus with hypertension
- Registration Number
- JPRN-UMIN000010604
- Lead Sponsor
- Iwasaki Naika Clinic
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
1)patients who wrere poorly controlled . 2)patients with secondary hypertension. 3)patients on HD. 4)pregnant patients. 5)patients who wrere allergic to telmisartan. 6)patients with heavy liver dysfunction. 7)patients with heavy renal dysfunction(Cre>3mg/dL).
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method blood pressure and HbA1c at 0, 4, 8, and 12 weeks after starting of treatment
- Secondary Outcome Measures
Name Time Method AST, ALT, gamma-GTP, LDL, HDL, TG, fasting glucose, adiponectin, safty at 0, 4, 8, and 12 weeks after starting of treatment